Results 191 to 200 of about 38,700 (229)

Formal and Informal Social Care in People With Rheumatic and Musculoskeletal Diseases: A Cross‐Sectional Multicenter Survey

Arthritis Care &Research, Volume 78, Issue 10, Page 1522-1531, October 2026.
Objective Rheumatic and musculoskeletal diseases (RMDs) are leading causes of physical disability, necessitating support with activities of daily living. This study describes social care received by patients with RMDs in two disparate regions of England: Salford (urban) and Norfolk (rural).
Mehreen Somro, Karen Durrant, William G. Dixon, John McBeth, Alex MacGregor, Max Yates, Jenny H. Humphreys   +6 more
wiley   +1 more source

Nutritional screening and extraglandular manifestations in Sjögren disease: a cross-sectional study using the controlling nutritional status score and prognostic nutritional index. [PDF]

Adv Rheumatol
Ösken S, Şahin D, Uzun NN, Yılmaz Öner S, Şen N, Tezcan ME.   +5 more
europepmc   +1 more source

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

Arthritis Care &Research, Volume 78, Issue 10, Page 1510-1521, October 2026.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source

Septic Pylephlebitis and Cavernous Transformation Presenting as Pyrexia of Unknown Origin: A Diagnostic Challenge. [PDF]

Clin Case Rep
Sarker A, Chowdhury P, Alam MR.
europepmc   +1 more source

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

Arthritis Care &Research, Volume 78, Issue 10, Page 1449-1466, October 2026.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci, Megan R. W. Barber, Ann E. Clarke, Sindhu R. Johnson, Anselm Mak, Hermine I. Brunner, Murat Inanc, Rosalind Ramsey‐Goldman, Guillermo Ruiz‐Irastorza, Ellen M. Ginzler, John G. Hanly, Alexandra Legge, Cynthia Aranow, Laurent Arnaud, Nathalie Costedoat‐Chalumeau, Dafna D. Gladman, Søren Jacobsen, Michelle Petri, Clovis A. Silva, Évelyne Vinet, Alexandre E. Voskuyl, SDI Revision Literature Review Groups, SDI Revision Delphi Panel, SDI Revision Item Reduction Committee, SDI Revision Clinical Domain Groups, Ian N. Bruce   +25 more
wiley   +1 more source

A patient-derived benchmark for evaluating large language models in connective tissue diseases: blinded multi-stakeholder assessment and guideline comparison. [PDF]

Rheumatol Int
Kremer P, Knitza J, Reichard A, Holzer MT, Xiong T, Schnoor U, Melderis S, Kötter I, Haase I, Krusche M.   +9 more
europepmc   +1 more source

Polymorphism of HLA class II alleles and tumor necrosis factor alpha promoter alleles in Hungarian patients with systemic lupus erythematosus and with primary Sjögren's syndrome [PDF]

, 2006
Kovács Attila
core  

Patient Journey, Disease Burden, Treatment Patterns, and the Impact of Delayed Diagnosis Among Patients With Sjögren's Disease: A Real‐World US Survey

ACR Open Rheumatology, Volume 8, Issue 10, October 2026.
Objective The aim of this study was to investigate disease burden, treatment patterns, and impact of delayed diagnosis on patient outcomes in Sjögren's disease (SjD) in a real‐world setting in the United States. Methods Data were drawn from the Adelphi Primary Sjögren's Syndrome Disease Specific Programme, a US‐based cross‐sectional collaborative ...
Anjana Lalla, Antton Egana, Jack Milligan, Nicola Massey, James Haughton   +4 more
wiley   +1 more source

Autoantibody Ordering Patterns Across a Tertiary Hospital: A Retrospective Audit. [PDF]

Open Access Rheumatol
Alqatari SG, Al Shubbar MD, Alodaini A, Obeid OE, Alhussain M, Aldajani K, Hasan M, Al-Abdulwahab AA, Alasaker NA, Alzuhair HM, AlNujaidi DY, Alwaheed AJ, Aldarweesh HH, AlSulaiman RS, Alghamdi R, Alkuwaiti MA.   +15 more
europepmc   +1 more source

Gephyrin Neurological Autoimmunity

Annals of Neurology, Volume 100, Issue 4, Page 781-787, October 2026.
Gephyrin is a postsynaptic scaffold protein essential for inhibitory neurotransmission. Gephyrin‐immunoglobulin G (IgG) was reported, decades ago, in a single case of paraneoplastic stiff‐person‐like syndrome, but its broader clinical relevance remains unknown.
Maria Chiara Pantuliano, Friederike A. Arlt, Naomi Arenson, Irena Dujmovic Basuroski, Divyanshu Dubey, Connie E. Lesnick, John R. Mills, Sean J. Pittock, Anastasia Zekeridou, Michael A. Lane, Andrew McKeon   +10 more
wiley   +1 more source